Female pattern hair loss

Journal of the American Academy of Dermatology

Volumn 47, Issue 5, 2002, Pages 795-

  Olsen, Elise A ^a,b   Hordinsky, Maria ^a,b   Roberts, Janet L ^a,b   Whiting, David A ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ALOPECIA; CASE REPORT; FEMALE; FEMALE TYPE ALOPECIA; HAIR LOSS; HUMAN; HYPERANDROGENISM; NOTE; ORAL CONTRACEPTION; POSTMENOPAUSE; PRIORITY JOURNAL; SCALP HAIR; TREATMENT OUTCOME;

EID: 0036828215     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.124068     Document Type: Article

References (7)

1. Shum KW, Cullen DR, Messenger AG. Hair loss in women with hyperandrogenism: Four cases responding to finasteride. J Am Acad Dermatol 2002;47:733-9.
2. Olsen EA. Female pattern hair loss. J Am Acad Dermatol 2001;45(Suppl):S69-S119.
3. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998;39:578-89.
4. The Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002;12:38-49.
5. Castello M, Tosi E, Perrone F, et al. Outcome of long-term treatment of the 5α-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up. Fertil Steril 1996;66:734-40.
6. Erenus M, Yucelten D, Durmesoglu F, et al. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism. Fertil Steril 1997;64:1000-3.
7. Price VH, Roberts JL, Hordinsky M, et al. Effect of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000;43:768-76.